Facts from the filing
Form 4 · Non-derivative, table I- Disclosed value
- −$811,366.50Shares × reported price
- Shares traded
- 3,465.749ResMed Common Stock
- Price per share
- $234.11Reported price. Read footnotes for ranges.
- % of reported position traded
- UnavailableThis security and ownership context
- Holdings after
- 476,419Direct
- Trade date
- Nov 11, 2026Tax withholding
- Filed
- Nov 13, 2026, 3:15 PM ET2-day reporting delay
- Accession
- 0000943819-26-000106Code F · Transaction 400422
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.